Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharmaceutical Industries has received the US Food and Drug Administration (FDA) tentative approval for the abbreviated new drug application (ANDA) of clopidogrel tablets USP.
Subscribe to our email newsletter
Clopidogrel tablets USP are indicated for the treatment for acute coronary syndrome, recent myocardial infarction (MI), recent stroke, or established peripheral arterial disease.
Sun Pharma‘s clopidogrel tablets USP, 75 mg are generic equivalent to Plavix tablets of Sanofi-aventis.
Plavix is used to prevent blood clots after a recent heart attack or stroke, and in people with certain disorders of the heart or blood vessels.